ArticleArchives of medical science : AMS2026
Epidemiological trends and burden of osteoarthritis in the United States: insights from the GBD 2021 study.
Article in Archives of medical science : AMS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: This study aimed to analyze the epidemiological trends and burden of osteoarthritis (OA) in the United States (U.S.) from 1990 to 2021 using data from the Global Burden of Disease (GBD) 2021 study, with a focus on sex, age, and geographic disparities. Material and methods: We used GBD 2021 data to examine OA incidence, prevalence, years lived with disability (YLDs), and age-standardized rates in the U.S., by gender, age group, and different states. Decomposition analysis was performed to assess contributions from population growth, aging, and epidemiological changes. Results: Between 1990 and 2021, OA incidence and prevalence in the U.S. increased by 80.3% and 90.3%, respectively. Females consistently exhibited a higher burden than males, with the highest incidence rate in the 55-59 age group. Geographically, California had the highest absolute case numbers, while Pennsylvania showed the highest age-standardized rates. Knee OA contributed most to disability, though hand OA dominated in the oldest populations. Decomposition analysis revealed that population growth (67.55%) was the primary driver of rising OA incidence. Conclusions: The OA burden in the U.S. has risen substantially over the past three decades, with marked disparities by sex, age, and region. Targeted public health strategies addressing prevention, early detection, and equitable healthcare access are urgently needed to mitigate this growing challenge.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.